Tau in Alzheimer's disease: Shaping the future patient journey

Abstract

The introduction of tau‐targeting Disease Modifying Therapies (DMT) to the existing treatment landscape for Alzheimer's disease (AD) holds the promise of enabling a more personalized approach for optimal and timely early‐stage treatment strategies.

The paper